https://ntp.niehs.nih.gov/go/13750

Target Organs and Levels of Evidence for TR-337

Toxicology and Carcinogenesis Studies of Nitrofurazone (CASRN 59-87-0) in F344/N Rats and B6C3F1 Mice (Feed Studies)

Chemical (Study Title)
CASRN		 Peer Review Date Route/Exposure Levels Study Laboratory
Nitrofurazone
59-87-0		 07/14/1987 Dosed-Feed
R: 0,310,620, M: 0,150,310 PPM/50 PER GROUP		 Physiological Research Laboratory

Levels of Evidence

Male Rats: Equivocal Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Preputial Gland: ADENOMA 8/50 8/50 2/50 OR CARCINOMA 1/50 8/50 5/50 COMBINED 9/50 16/50 7/50
  • Skin: SEBACEOUS GLAND ADENOMA 0/50 0/50 4/50; TRICHOEPITHELIOMA 0/50 0/50 1/50
  • Mesothelium (Abdominal Cavity/Tunica Vaginalis): MESOTHELIOMA 0/50 7/50 2/50
Non-Neoplastic Lesions
  • TESTES: DEGENERATION 12/50 49/50 47/50
  • KNEE JOINT: DEGENERATION 5/50 32/50 48/50
Female Rats: Clear Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Mammary Gland: FIBROADENOMA 8/49 36/50 36/50
Non-Neoplastic Lesions
  • KNEE JOINT: DEGENERATION 4/49 30/50 39/50
Male Mice: No Evidence
Female Mice: Clear Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Ovary: GRANULOSA CELL TUMOR 1/47 4/50 9/50; BENIGN MIXED TUMORS 0/47 17/50 20/50
Non-Neoplastic Lesions
  • OVARY: ATROPHY 7/47 44/50 38/50